Effect of ultrasound-guided sclerotherapy on solid nodules of thyroid cyst

中国基层医药 Pub Date : 2020-03-15 DOI:10.3760/CMA.J.ISSN.1008-6706.2020.06.021

Xiaolin Zhang, J. Lu, Weijie Zhao, Nana Xin, Jianzhong Ding

引用次数: 0

Abstract

目的观察超声引导下硬化治疗甲状腺囊实性结节的临床效果。方法选取晋城煤业集团总医院2016年7月至2019年6月收治的甲状腺结节患者49例(57个囊实性结节)，进行超声引导下硬化治疗，分析治疗效果、治疗前后结节体积的变化及不良反应。结果经过超声引导下硬化治疗，57个囊实性结节有效51个，总有效率为89.5%；治疗前结节体积(12.4±5.2)cm3，治疗后体积(2.8±3.1)cm3，治疗前后差异有统计学意义(t＝11.97，P<0.05)；49例患者中出现疼痛2例，术中出血1例，并发症发生率为6.1%(3/49)。结论超声引导下硬化治疗甲状腺囊实性结节疗效确切，操作简单，无严重并发症。

查看原文

微信好友朋友圈 QQ好友复制链接

本刊更多论文

超声引导下硬化治疗甲状腺囊肿实体结节疗效观察

Objective: To observe the clinical effect of ultrasound guided sclerotherapy for thyroid cystic solid nodules. Method: 49 patients with thyroid nodules (57 cystic solid nodules) admitted to Jincheng Coal Industry Group General Hospital from July 2016 to June 2019 were selected for ultrasound guided sclerotherapy. The treatment effect, changes in nodule volume before and after treatment, and adverse reactions were analyzed. After ultrasound guided sclerotherapy, 51 out of 57 cystic solid nodules were effective, with a total effective rate of 89.5%; The volume of nodules before treatment was (12.4 ± 5.2) cm3, and the volume after treatment was (2.8 ± 3.1) cm3. There was a statistically significant difference before and after treatment (t=11.97, P<0.05); Among the 49 patients, 2 experienced pain and 1 experienced intraoperative bleeding, with a complication rate of 6.1% (3/49). Conclusion: Ultrasound guided sclerotherapy for thyroid cystic solid nodules is effective, easy to operate, and has no serious complications.

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文去求助

来源期刊

中国基层医药

CiteScore

0.10

自引率

0.00%

发文量

32251

期刊介绍： Since its inception, the journal "Chinese Primary Medicine" has adhered to the development strategy of "based in China, serving the grassroots, and facing the world" as its publishing concept, reporting a large amount of the latest medical information at home and abroad, prospering the academic field of primary medicine, and is praised by readers as a medical encyclopedia that updates knowledge. It is a core journal in China's medical and health field, and its influence index (CI) ranks Q2 in China's academic journals in 2022. It was included in the American Chemical Abstracts in 2008, the World Health Organization Western Pacific Regional Medical Index (WPRIM) in 2009, and the Japan Science and Technology Agency Database (JST) and Scopus Database in 2018, and was included in the Wanfang Data-China Digital Journal Group and the China Academic Journal Comprehensive Evaluation Database.